113 related articles for article (PubMed ID: 9812227)
1. Results of clinically downstaging cervical cancer in a cytological screening programme.
Misra JS; Das K; Chandrawati
Diagn Cytopathol; 1998 Nov; 19(5):344-8. PubMed ID: 9812227
[TBL] [Abstract][Full Text] [Related]
2. Results of longterm hospital based cytological screening in asymptomatic women.
Misra JS; Singh U
Diagn Cytopathol; 2006 Mar; 34(3):184-7. PubMed ID: 16470854
[TBL] [Abstract][Full Text] [Related]
3. The role of routine outpatient cytological screening for early detection of carcinoma of the cervix in India.
Engineer AD; Misra JS
Diagn Cytopathol; 1987 Mar; 3(1):30-4. PubMed ID: 3568970
[TBL] [Abstract][Full Text] [Related]
4. Cervicovaginal cytology in patients 16 years of age and younger.
Diller C; Murphy G; Lauchlan SC
Acta Cytol; 1983; 27(4):426-8. PubMed ID: 6576542
[TBL] [Abstract][Full Text] [Related]
5. Cytologic evidence of the association of different infective lesions with dysplastic changes in the uterine cervix.
Chakrabarti RN; Dutta K; Sarkhel T; Maity S
Eur J Gynaecol Oncol; 1992; 13(5):398-402. PubMed ID: 1336729
[TBL] [Abstract][Full Text] [Related]
6. Single life time cytological screening in high risk women as an economical and feasible approach to control cervical cancer in developing countries like India.
Misra JS; Srivastava AN; Das V
Asian Pac J Cancer Prev; 2015; 16(3):859-62. PubMed ID: 25735373
[TBL] [Abstract][Full Text] [Related]
7. Risk-factors and strategies for control of carcinoma cervix in India: hospital based cytological screening experience of 35 years.
Misra JS; Srivastava S; Singh U; Srivastava AN
Indian J Cancer; 2009; 46(2):155-9. PubMed ID: 19346651
[TBL] [Abstract][Full Text] [Related]
8. Assessing the feasibility of single lifetime PAP smear evaluation between 41-50 years of age as strategy for cervical cancer control in developing countries from our 32 years of experience of hospital-based routine cytological screening.
Misra JS; Gupta HP; Das V
Diagn Cytopathol; 2004 Dec; 31(6):376-9. PubMed ID: 15540174
[TBL] [Abstract][Full Text] [Related]
9. Mild cervical dysplasia. Experience in a family planning clinic.
Sondheimer SJ; Casey MV; Rubin M; Mangan C; Atkinson B; Huggins GR
J Reprod Med; 1983 Jul; 28(7):489-95. PubMed ID: 6887154
[TBL] [Abstract][Full Text] [Related]
10. [Cervical screening and surveillance of the cervix uteri before the age of 20].
Benmoura D; Sperandeo D; Duprez D
J Gynecol Obstet Biol Reprod (Paris); 1986; 15(1):63-71. PubMed ID: 3701000
[TBL] [Abstract][Full Text] [Related]
11. Screening and treatment of sexually transmitted diseases Part 2: trichomonas, human papillomavirus infection, and genital herpes simplex virus.
McClain N; Cheung K; Girardet R; Lahoti S; McNeese M;
J Pediatr Health Care; 2000; 14(3):130-2. PubMed ID: 10823973
[No Abstract] [Full Text] [Related]
12. Results of Cervical Cancer Screening in the Rural Population of Lucknow West, India, through a Camp Approach.
Misra JS; Srivastava AN; Gupta HP
Acta Cytol; 2018; 62(4):273-278. PubMed ID: 29898440
[TBL] [Abstract][Full Text] [Related]
13. Epidemiologic differences between candidial and trichomonal infections as detected in cytologic smears in Taiwan.
Wang PD; Lin RS
Public Health; 1995 Nov; 109(6):443-50. PubMed ID: 8570805
[TBL] [Abstract][Full Text] [Related]
14. Community-based screening of cervical cancer in a low prevalence area of India: a cross sectional study.
Yasmeen J; Qurieshi MA; Manzoor NA; Asiya W; Ahmad SZ
Asian Pac J Cancer Prev; 2010; 11(1):231-4. PubMed ID: 20593962
[TBL] [Abstract][Full Text] [Related]
15. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
16. Six-year follow-up survey of sexually transmitted diseases in Brasilia, the Capital of Brazil.
Simões-Barbosa A; Coutinho Feijó G; da Silva JX; Rama Leal II; Wanderley Paes Barbosa T
Braz J Infect Dis; 2002 Jun; 6(3):110-8. PubMed ID: 12144746
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cervical smears at King Hussein Medical Centre, Jordan, over three and a half years.
Malkawi SR; Abu Hazeem RM; Hajjat BM; Hajjiri FK
East Mediterr Health J; 2004; 10(4-5):676-9. PubMed ID: 16335662
[TBL] [Abstract][Full Text] [Related]
18. Implications of gynaecological abnormalities in pre-selection criteria for cervical screening: preliminary evaluation of 3602 subjects in south India.
Sujathan K; Kannan S; Pillai KR; Mathew A; Joseph M; Symalakumari B; Nair MK
Cytopathology; 1995 Apr; 6(2):75-87. PubMed ID: 7795168
[TBL] [Abstract][Full Text] [Related]
19. Epidemiologic analysis of Trichomonas vaginalis infection in inflammatory smears.
Sardana S; Sodhani P; Agarwal SS; Sehgal A; Roy M; Singh V; Bhatnagar P; Murthy NS
Acta Cytol; 1994; 38(5):693-7. PubMed ID: 8091899
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of downstaging in the detection of cervical neoplasia in Kolkata, India.
Basu P; Sankaranarayanan R; Mandal R; Roy C; Das P; Choudhury D; Datta K; Karamakar S; Tsu V; Chakrabarti RN; Siddiqi M;
Int J Cancer; 2002 Jul; 100(1):92-6. PubMed ID: 12115593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
